vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and GRAHAM CORP (GHM). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $56.7M, roughly 1.1× GRAHAM CORP). GRAHAM CORP runs the higher net margin — 5.0% vs -70.9%, a 75.9% gap on every dollar of revenue. On growth, GRAHAM CORP posted the faster year-over-year revenue change (20.5% vs 8.1%). GRAHAM CORP produced more free cash flow last quarter ($2.4M vs $-1.8M). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 7.5%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Graham Holdings Company is a diversified American conglomerate holding company. Headquartered in Arlington County, Virginia, and incorporated in Delaware, it was formerly the owner of The Washington Post newspaper and Newsweek magazine.
CTKB vs GHM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $56.7M |
| Net Profit | $-44.1M | $2.8M |
| Gross Margin | 52.9% | 23.8% |
| Operating Margin | -9.0% | 5.5% |
| Net Margin | -70.9% | 5.0% |
| Revenue YoY | 8.1% | 20.5% |
| Net Profit YoY | -557.1% | 79.2% |
| EPS (diluted) | — | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $56.7M | ||
| Q3 25 | $52.3M | $66.0M | ||
| Q2 25 | $45.6M | $55.5M | ||
| Q1 25 | $41.5M | $59.3M | ||
| Q4 24 | $57.5M | $47.0M | ||
| Q3 24 | $51.5M | $53.6M | ||
| Q2 24 | $46.6M | $50.0M | ||
| Q1 24 | $44.9M | $49.1M |
| Q4 25 | $-44.1M | $2.8M | ||
| Q3 25 | $-5.5M | $3.1M | ||
| Q2 25 | $-5.6M | $4.6M | ||
| Q1 25 | $-11.4M | $4.4M | ||
| Q4 24 | $9.6M | $1.6M | ||
| Q3 24 | $941.0K | $3.3M | ||
| Q2 24 | $-10.4M | $3.0M | ||
| Q1 24 | $-6.2M | $1.3M |
| Q4 25 | 52.9% | 23.8% | ||
| Q3 25 | 52.7% | 21.7% | ||
| Q2 25 | 52.3% | 26.5% | ||
| Q1 25 | 48.6% | 27.0% | ||
| Q4 24 | 58.5% | 24.8% | ||
| Q3 24 | 56.3% | 23.9% | ||
| Q2 24 | 54.6% | 24.8% | ||
| Q1 24 | 51.3% | 25.9% |
| Q4 25 | -9.0% | 5.5% | ||
| Q3 25 | -17.6% | 6.5% | ||
| Q2 25 | -23.3% | 8.9% | ||
| Q1 25 | -36.1% | 9.3% | ||
| Q4 24 | 5.2% | 4.7% | ||
| Q3 24 | -8.2% | 7.9% | ||
| Q2 24 | -18.3% | 6.5% | ||
| Q1 24 | -23.9% | 3.1% |
| Q4 25 | -70.9% | 5.0% | ||
| Q3 25 | -10.5% | 4.7% | ||
| Q2 25 | -12.2% | 8.3% | ||
| Q1 25 | -27.5% | 7.4% | ||
| Q4 24 | 16.8% | 3.4% | ||
| Q3 24 | 1.8% | 6.1% | ||
| Q2 24 | -22.4% | 5.9% | ||
| Q1 24 | -13.8% | 2.7% |
| Q4 25 | — | $0.25 | ||
| Q3 25 | — | $0.28 | ||
| Q2 25 | — | $0.42 | ||
| Q1 25 | — | $0.40 | ||
| Q4 24 | — | $0.14 | ||
| Q3 24 | — | $0.30 | ||
| Q2 24 | — | $0.27 | ||
| Q1 24 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $22.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $341.7M | $131.3M |
| Total Assets | $461.5M | $292.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $22.3M | ||
| Q3 25 | $93.3M | $20.6M | ||
| Q2 25 | $75.5M | $10.8M | ||
| Q1 25 | $95.3M | $21.6M | ||
| Q4 24 | $98.7M | $30.0M | ||
| Q3 24 | $162.3M | $32.3M | ||
| Q2 24 | $177.9M | $21.6M | ||
| Q1 24 | $168.8M | $16.9M |
| Q4 25 | $341.7M | $131.3M | ||
| Q3 25 | $378.6M | $127.6M | ||
| Q2 25 | $377.6M | $123.4M | ||
| Q1 25 | $379.6M | $119.6M | ||
| Q4 24 | $395.7M | $114.4M | ||
| Q3 24 | $385.5M | $112.5M | ||
| Q2 24 | $389.1M | $108.2M | ||
| Q1 24 | $392.6M | $105.6M |
| Q4 25 | $461.5M | $292.9M | ||
| Q3 25 | $494.9M | $287.0M | ||
| Q2 25 | $493.3M | $252.3M | ||
| Q1 25 | $482.6M | $264.1M | ||
| Q4 24 | $499.5M | $264.3M | ||
| Q3 24 | $491.2M | $249.5M | ||
| Q2 24 | $483.7M | $244.2M | ||
| Q1 24 | $492.1M | $233.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $4.8M |
| Free Cash FlowOCF − Capex | $-1.8M | $2.4M |
| FCF MarginFCF / Revenue | -2.9% | 4.3% |
| Capex IntensityCapex / Revenue | 1.6% | 4.1% |
| Cash ConversionOCF / Net Profit | — | 1.67× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $-6.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $4.8M | ||
| Q3 25 | $-3.9M | $13.6M | ||
| Q2 25 | $108.0K | $-2.3M | ||
| Q1 25 | $-125.0K | $-3.6M | ||
| Q4 24 | $2.0M | $5.2M | ||
| Q3 24 | $13.2M | $13.9M | ||
| Q2 24 | $6.2M | $8.7M | ||
| Q1 24 | $4.0M | $8.6M |
| Q4 25 | $-1.8M | $2.4M | ||
| Q3 25 | $-4.6M | $9.4M | ||
| Q2 25 | $-1.5M | $-9.3M | ||
| Q1 25 | $-974.0K | $-8.7M | ||
| Q4 24 | $1.1M | $-2.1M | ||
| Q3 24 | $12.2M | $10.4M | ||
| Q2 24 | $5.2M | $5.7M | ||
| Q1 24 | $3.4M | $4.6M |
| Q4 25 | -2.9% | 4.3% | ||
| Q3 25 | -8.7% | 14.3% | ||
| Q2 25 | -3.2% | -16.7% | ||
| Q1 25 | -2.3% | -14.7% | ||
| Q4 24 | 1.9% | -4.5% | ||
| Q3 24 | 23.7% | 19.5% | ||
| Q2 24 | 11.0% | 11.5% | ||
| Q1 24 | 7.6% | 9.4% |
| Q4 25 | 1.6% | 4.1% | ||
| Q3 25 | 1.3% | 6.3% | ||
| Q2 25 | 3.5% | 12.6% | ||
| Q1 25 | 2.0% | 8.7% | ||
| Q4 24 | 1.6% | 15.6% | ||
| Q3 24 | 2.0% | 6.5% | ||
| Q2 24 | 2.3% | 6.0% | ||
| Q1 24 | 1.3% | 8.2% |
| Q4 25 | — | 1.67× | ||
| Q3 25 | — | 4.40× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | — | -0.81× | ||
| Q4 24 | 0.21× | 3.29× | ||
| Q3 24 | 14.05× | 4.25× | ||
| Q2 24 | — | 2.94× | ||
| Q1 24 | — | 6.45× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
GHM
| Defense | $35.3M | 62% |
| Energy And Process | $18.3M | 32% |
| Space | $3.1M | 6% |
